 BUFFALO, N.Y., June 07, 2021 GLOBE NEWSWIRE -- 22nd Century Group, Inc. NYSE American: XXII, a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hempcannabis research, today announced new initiatives to strengthen and maximize revenue opportunities in its hempcannabis franchise. Included in these developments is the announcement of strategic partnerships with two plant breeders in the northern and southern hemispheres providing the Company with year-round growing capabilities, close partnership activities being conducted with Aurora Cannabis, and the establishment of a newly created Canadian subsidiary. These newest developments further support 22nd Centurys plans for multiple avenues of hempcannabis revenue that will begin to be realized in late 2021. 